Sarcoma News

The risk for endocrinopathies increased substantially over time among childhood cancer survivors, especially among those who received high-risk therapies, according to the results of an analysis from the Childhood Cancer Survivor Study.

Cancer treatment centers in the United States spent $173 million on advertising in the year 2014, according to a research letter published in JAMA Internal Medicine.

Adjuvant radiation appeared to benefit older patients with soft tissue sarcoma more than younger patients, according to retrospective study results.

The FDA approved dronabinol oral solution for the treatment of patients with cancer who experience chemotherapy-induced nausea and vomiting, according to a press release from the agent’s manufacturer.

Short sleep duration and frequent snoring prior to cancer diagnosis may shorten OS among postmenopausal women with breast cancer.

Recent research has led to meaningful advances in the diagnosis of primary musculoskeletal tumors. From information about tumor-specific phenotypes to improved imaging sequences, sources told Orthopaedics Today Europe they have seen slow, but steady progress in this area.

PHILADELPHIA — Fox Chase Cancer Center today hosted a Regional Cancer Moonshot Summit in conjunction with the National Cancer Moonshot Summit held in Washington, D.C., marking the first time that stakeholders representing all cancer types convened under one national charge.

Nancy E. Davidson, MD, director of University of Pittsburgh Cancer Institute, took over as president of the American Association for Cancer Research this spring.

Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation, has been named acting director of the agency’s new Oncology Center of Excellence.

Lifestyle choices can contribute considerably to a person’s cancer risk, as well the outcomes they achieve after they are diagnosed with a malignancy.